In this webinar we will discuss how 3D cell culture overcomes the limitations of traditional 2D culture when it comes to predicting the therapeutic potential of pharmaceutical compounds in development. We will describe how our Reconstructed Lung 3D culture platform (r-Lung) has successfully been adopted for testing of anti-cancer agents in high-throughput screening (HTS) format using the Tecan Freedom EVO® liquid handler and Tecan D300e Digital Dispenser, and how the platform provides a physiologically-relevant, automated 3D HTS system that can be incorporated throughout the drug development workflow for reliable identification of anti-cancer agents.
Predictive Oncology
Bio.News features Predictive Oncology
“The way in which Predictive Oncology utilizes the power of predictive models offers the potential to optimize the utilization of resources, improve patient outcomes, and